Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
2019 · Annals of Hematology · 16 citations
https://doi.org/10.1007/s00277-019-03830-8
J
Jamie Garside
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
245
Citations
9
h-index
9
i10-index
Jamie Garside is an academic researcher from Health Economics and Outcomes Research (United Kingdom). The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Lymphoma Diagnosis and Treatment & Genetic factors in colorectal cancer. The author has an h-index of 9, co-authored 38 publications.
Papers by this author
worksA note on the relationship between age and health-related quality of life assessment
2018 · Quality of Life Research · 9 citations
https://doi.org/10.1007/s11136-018-2071-5
Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma
2020 · PharmacoEconomics - Open · 5 citations
https://doi.org/10.1007/s41669-020-00231-w
Quality-adjusted time without symptoms of disease progression or toxicity of treatment in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel versus carboplatin-paclitaxel
2025 · International Journal of Gynecological Cancer · 1 citations
https://doi.org/10.1016/j.ijgc.2025.101935
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat